Today

Agents

Chat

Arena

Discover

More

App

Gt Biopharma Reports Second Quarter 2026 Financial Results - GTBP News | Rallies

Gt Biopharma Reports Second Quarter 2026 Financial Results

GTBP•2026-08-14

Second-quarter 2026 financial results

Aug. 14 (Reuters) - GT Biopharma Inc (GTBP.O):

GT Biopharma reports second-quarter 2026 financial results
GT Biopharma Inc - cash balance as of June 30 of about $5.1 million anticipated to provide sufficient cash runway through Q4 2026

Related News

Star Equity Holdings Enters Into Merger Agreement To Acquire Harte Hanks

HHS•2026-08-14

Reading International Q2 FY26 net income swings to USD 2.31 million; revenue rises 11% to USD 66.9 million

RDI•2026-08-14

Greenland Technologies Q2 FY26 swings to profit of $4.9 million; revenue rises 37.6% to $29.9 million

GTEC•2026-08-14

Tesla Nears Unveiling Of Radical New ‘Flying’ Roadster- The Information

TSLA•2026-08-14

Nutra Pharma delays Q2 10-Q filing, citing need for more time to finalize financials

NPHC•2026-08-14